Clinical trials
Obesity & Overweight clinical trials
Below are recruiting obesity & overweight clinical trials, each written for real people, not researchers. We’re tracking 486 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07229027Recruiting
Global overweight and obesity registry study
This study aims to develop better ways to measure how overweight or obesity affects your life, including severity, quality of life, and costs. You will fill out surveys to help researchers understand your experience.
Milton KeynesAges 18 years+ - NCT06967389Recruiting
Helping kids with severe obesity reduce heart risks
This trial tests whether semaglutide can lower heart disease risks in children with extreme obesity. It aims to improve weight and heart health over time.
Lexington, KentuckyAges 12–17 - NCT06722443Enrolling by invitation
Probiotics and Prebiotics for Obesity
This trial tests whether adding probiotics and prebiotics to your diet can help with obesity and related health problems like prediabetes, diabetes, high cholesterol, or high blood pressure.
Granada, SpainAges 18–75 - NCT07284901RecruitingPhase 3
Weekly injection for diabetes and weight loss
This study tests an experimental once-weekly injection called ribupatide for people with type 2 diabetes and overweight. It aims to help them lose weight and better control their blood sugar.
Cullman, AlabamaAges 18 years+ - NCT06937099RecruitingPhase 3
Testing two drugs for Crohn's with weight issues
This trial tests two study drugs, mirikizumab and tirzepatide, in people with moderate to severe Crohn's disease who also have overweight or obesity. The goal is to see if these treatments can help control Crohn's symptoms and inflammation.
Dothan, AlabamaAges 18–70 - NCT07721597RecruitingEarly Phase 1
Testing ZP6590 in Men of Various Weights
This trial tests an experimental medication called ZP6590 given as injections. It's for men who are at a normal weight, overweight, or have obesity, and studies how safe and well-tolerated the drug is in different doses.
Neuss, North Rhine-WestphaliaAges 18–60 - NCT07575399RecruitingPhase 3
Switching to a New Weight-Loss Medication From Current GLP-1
This trial tests whether switching from your current GLP-1 medication (like Ozempic or Wegovy) to a new drug called maridebart cafraglutide works as well or better for weight management. You must have already lost at least 10% of your body weight on your current GLP-1 and be doing well with it.
Pelham, AlabamaAges 18–99 - NCT06187896Recruiting
Remimazolam to prevent low oxygen during hysteroscopy in overweight women
This trial tests whether a sedation drug called remimazolam can reduce the risk of severe low oxygen levels during a hysteroscopy for overweight or obese women undergoing fertility treatment. If you qualify, you may receive a gentler sedation option that could be safer for you.
Shanghai, Shanghai MunicipalityAges 20–50 - NCT06562465Recruiting
Overweight and obesity prevention for preschool children
This study tests a 4-month diet and exercise program to help overweight or obese preschool children. It focuses on healthy habits and regular check-ups to see if the program helps children manage their weight.
Chongqing, Chongqing MunicipalityAges 3–6 - NCT07743450RecruitingPhase 3
Once-daily pill for weight loss in people with type 2 diabetes
This study tests an oral medication, ASC30, to see if it helps people with type 2 diabetes who are overweight or obese lose weight and improve blood sugar control. It is a once-daily pill that may offer a new treatment option.
Birmingham, AlabamaAges 18 years+ - NCT07321886RecruitingPhase 3
Study of eloralintide for people with obesity or overweight
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
Tuscaloosa, AlabamaAges 18 years+ - NCT07654972RecruitingPhase 1
Study of a new weight loss drug in healthy people with obesity or overweight
This study tests a new medication (LY4174794) for weight loss in people who are overweight or have obesity. It will help see if the drug is safe and how the body processes it.
San Antonio, TexasAges 18–65 - NCT07114289Recruiting
Breathing test methods for overweight patients on ventilators
This study compares two ways of testing if overweight or obese patients can breathe on their own after being on a ventilator. You will be randomly assigned to one of two breathing trials (pressure support or a T-piece) to see which works better for helping you get off the ventilator.
TaipeiAges 18 years+ - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Birmingham, AlabamaAges 18 years+ - NCT07326111RecruitingPhase 4
Tirzepatide for PCOS and weight in women
This study tests if tirzepatide (a once-weekly injection) can improve periods and metabolic health in women with PCOS who are overweight. If you have PCOS, irregular cycles, and a BMI of 27 or higher, you might qualify.
BochumAges 18–45 - NCT07228130Recruiting
A weight loss study using a smartphone app
This study tests a smartphone app to help with weight loss by tracking habits. It may be a good fit if you are ready to try a new approach to managing your weight.
Providence, Rhode IslandAges 18–70 - NCT06512818Enrolling by invitationPhase 1/Phase 2
Testing Psiguavin for weight loss in obesity
This study tests a natural supplement made from guava (called Psiguavin) to see if it helps with weight loss in people who are overweight or have obesity. Participants will take the supplement and be monitored for weight changes and safety.
MurciaAges 18–65 - NCT07255274Recruiting
Sleep help for teens with overweight or obesity
This study tests whether a behavior-based sleep program can help teenagers aged 13–17 who are overweight or have obesity and also have sleep problems. The goal is to see if improving sleep can help with weight management.
CovilhaAges 13–17 - NCT07351058RecruitingPhase 3
Enicepatide for weight loss in people with type 2 diabetes
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
Guntersville, AlabamaAges 18 years+ - NCT07351045RecruitingPhase 3
Study of enicepatide for weight loss in obesity or overweight
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
Anniston, AlabamaAges 18 years+ - NCT04184479Recruiting
Test of a LEVAmethod program for adults with overweight
This study tests whether the LEVAmethod program helps adults with overweight or obesity when delivered in primary care. You may be asked to use digital tools and complete follow-up during the program.
GothenburgAges 18–75 - NCT07743463RecruitingPhase 3
Daily pill for weight loss in adults with overweight or obesity
This trial tests an investigational once-daily pill (ASC30) to see if it can help adults with overweight or obesity lose weight. You may be able to join if you have a high body mass index (BMI) and have tried to lose weight before.
Birmingham, AlabamaAges 18 years+ - NCT07215559RecruitingPhase 2
Study of new drugs for obesity with type 2 diabetes
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
Gilbert, ArizonaAges 18–75 - NCT07316179Recruiting
Predicting breathing tube placement in weight-loss surgery
This study compares two methods—a standard risk score (El Ganzouri index) and an ultrasound exam—to predict how easy it will be to place a breathing tube during weight-loss surgery. The goal is to find the best way to keep patients safe during anesthesia.
Antalya, AntalyaAges 18–65
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity & overweight?
- Yes. Clin2 currently lists 486 recruiting obesity & overweight studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity & overweight trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity & overweight trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.